A detailed history of Ameriprise Financial Inc transactions in Galapagos Nv stock. As of the latest transaction made, Ameriprise Financial Inc holds 80,825 shares of GLPG stock, worth $2.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,825
Previous 106,024 23.77%
Holding current value
$2.21 Million
Previous $2.63 Million 11.46%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$24.2 - $30.67 $609,815 - $772,853
-25,199 Reduced 23.77%
80,825 $2.33 Million
Q2 2024

Aug 14, 2024

BUY
$24.78 - $32.48 $44,752 - $58,658
1,806 Added 1.73%
106,024 $2.63 Million
Q1 2024

May 15, 2024

SELL
$32.2 - $42.44 $84,492 - $111,362
-2,624 Reduced 2.46%
104,218 $3.36 Million
Q4 2023

Feb 14, 2024

BUY
$31.87 - $40.71 $557,661 - $712,343
17,498 Added 19.58%
106,842 $4.34 Million
Q3 2023

Nov 14, 2023

BUY
$34.17 - $42.98 $1.34 Million - $1.68 Million
39,197 Added 78.16%
89,344 $3.09 Million
Q2 2023

Aug 14, 2023

BUY
$37.4 - $44.52 $442,816 - $527,116
11,840 Added 30.91%
50,147 $2.04 Million
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $1.4 Million - $1.84 Million
38,307 New
38,307 $1.48 Million
Q3 2020

Nov 16, 2020

SELL
$122.47 - $213.56 $234,285 - $408,540
-1,913 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$185.52 - $231.25 $102,221 - $127,418
551 Added 40.46%
1,913 $377,000
Q1 2020

May 15, 2020

SELL
$143.0 - $274.03 $3,718 - $7,124
-26 Reduced 1.87%
1,362 $267,000
Q4 2019

Feb 14, 2020

BUY
$146.12 - $215.82 $202,814 - $299,558
1,388 New
1,388 $287,000
Q3 2019

Nov 14, 2019

SELL
$130.44 - $187.64 $332,882 - $478,857
-2,552 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$111.45 - $128.93 $59,068 - $68,332
530 Added 26.21%
2,552 $329,000
Q1 2019

May 15, 2019

BUY
$89.61 - $117.78 $181,191 - $238,151
2,022 New
2,022 $238,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.8B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.